Navigation Links
Genstruct Added to The Biomarker Consortium's Rapidly Growing Roster of Industry Experts
Date:11/4/2008

CAMBRIDGE, Mass., Nov. 4 /PRNewswire/ -- Genstruct Inc., a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better develop novel therapeutics and molecular diagnostics, today announced that it has become a member of The Biomarker Consortium, a public/private research partnership managed by the Foundation for the National Institutes on Health (FNIH), and founded by the National Institutes of Health (NIH), the Food and Drug Administration (FDA) and the Pharmaceutical Research and Manufacturers of America (PhRMA).

"Being an active contributor in The Biomarker Consortium's initiatives to discover, develop and qualify biological markers to support new drug development, preventative medicine and medical diagnostics is an excellent opportunity for Genstruct to share our knowledge as well as collaborate with other industry experts to help accelerate drug discovery and development," said Dr. Keith O. Elliston, president and CEO at Genstruct. "Our technology allows one to identify mechanism-based biomarkers which can then be qualified and validated in clinical studies rather than working backwards from clinical correlations, enabling us to provide a unique viewpoint to this group based on our experience."

Biomarkers (biological markers) are molecular, biological or physical characteristics that indicate a specific, underlying physiologic state to identify risk for disease, to make a diagnosis and to guide treatment, according to The Biomarker Consortium. The group aims to rapidly identify and qualify biomarkers to support basic and translational research, guide clinical practice and, ultimately, support the development of safe and effective medicines and treatments.

Genstruct's proprietary Causal Network(TM) Modeling platform for systems biology enables scientists to break down cognitive barriers that impede critical path research. Genstruct's computable models of biology lead directly to the discovery
'/>"/>

SOURCE Genstruct Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
2. Genstructs Andrea Matthews Selected for Mass High Techs People to Watch Under 30
3. Genstruct and Sirtris Pharmaceuticals Win Bio-IT Worlds Best Practices Award
4. Genstruct Names Louis Latino VP of Sales
5. Genstruct Expands Team with New VP of Engineering
6. Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI)
7. Eurand Added to NASDAQ Biotechnology Index
8. Biodel Inc. Added to NASDAQ Biotechnology Index
9. Fungitell(R) CE Marked, Referenced in IDSA and NCCN Guidelines and Added to EORTC-MSG Revised Definitions of Invasive Fungal Disease
10. Caliper Life Sciences Added to Russell 3000(R) Index
11. Bioheart, Inc., Added to Russell Microcap Index

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...re-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) tod...uarter ended September 30, 2009. GenVec reported a...e three months ended September 30, 2009 compared t...the comparable quarter of 2008. For the nine month...$14.1 million ($0.15 per share), compared to a net...
(Date:11/5/2009)...er 5, 2009 at 4:30 p.m. Eastern Time , BOTHEL...- OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or ...udited financial results for the third quarter and... the Company,s highlights for the third quarter of...flect the operations of OncoGenex Technologies Inc...
(Date:11/5/2009)...Newswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNM...receptor-based technologies to discover novel flav...ent supply industries, today provided a corporate ...d quarter ended September 30, 2009. Revenues were...red to $4.0 million for the third quarter of 2008,...
(Date:11/5/2009)...nd vision correction experts listed in the Trusted...t the recently concluded American Academy of Ophth...o, California. Dr. Stephen Brint, MD, Dr. Frederic...Peter Rapoza, MD, Dr. Michael Raizman, MD, Dr. Jam...rd Manche, MD, and Dr. Parag Majmudar, MD, all lea...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9
... Scientific Group,Inc. (OTC Bulletin Board: BMSN) ...ewly created positions on its management team. Fen... and development company as Laboratory/Scientific,...Assurance Director. , "Dr. Feng Lin and Marily...trative operations of BMSN,s laboratories to ensur...
...- ImmunoVaccine Technologies Inc. (IVT), a vaccine...greement with the National Institute of Allergy an...itutes of Health (NIH), in Maryland, USA. The rese...gens in DepoVax(TM), IVT,s vaccine enhancement sys...malaria. , "NIAID is a world leader in the study o...
...ta Support Picoplatin in Combination with Docetaxe...Castration-Resistant Prostate Cancer - , , - Resu...nical Oncology,s 2009 Genitourinary Cancers Sympos...oniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a ...cology therapies, today announced the presentation...
Other Biology Technology:Bio-Matrix Scientific Group Announces New Hires to Management Team 2ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria 2Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer 2Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer 3Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer 4Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer 5
(Date:11/4/2009)... N.J., Oct. 20 Quest Dia...eading provider of diagnostic testing, information...r ended September 30, 2009, income from continuing...uted share, from $160 million, or $0.81 per dilute...hird quarter results were reduced by a $0.03 per s...
(Date:11/4/2009)... Mass., Oct. 20 Aware, I...and technology and biometrics software, today repo...d September 30, 2009. ,, Michael Tzannes, Awa...Earlier today, we announced an agreement to sell o..., a new fabless semiconductor company being spun o...
(Date:11/4/2009)..., Calif., Oct. 23 GenVault Corpora...management for genomic discovery, medicine and ide....D., GenVault,s President and CEO, will be present... on October 26th and 27th in La Jolla, CA. ,, D... overview of the company together with recent cust...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2CSC Announces Agreement to Provide Billing Service to Littleton Internal Medicine Associates 51724 1Aurora Health Care Sponsors Education Event to Improve Care for the Elderly 51719 1Aurora Health Care Sponsors Education Event to Improve Care for the Elderly 51719 2Aurora Health Care Sponsors Education Event to Improve Care for the Elderly 51719 3Aurora Health Care Sponsors Education Event to Improve Care for the Elderly 51719 4United Physicians Goes Green Effective August 1st 2009 51715 1United Physicians Goes Green Effective August 1st 2009 51715 2
...rain forest peoples in Latin America are preparing...al decision-making on climate issues. A major land...s of the UN Framework Convention on Climate Change... when forest leaders from 13 countries and experts...ange and the Peoples of the Forest: Advancing in t...
...have known for centuries: eyes really are windows ...y published in the April 2008 print issue of The F...researchers describe the development of gene probe...to monitor and detect tissue repair in the brain o...lve a risky, invasive, and relatively slow process...
...iewed in the streets of Edinburgh are unaware of o... the eradication of smallpox from the world over ...General Microbiology (SGM), in conjunction with th...vealed that 87% of 200 individuals questioned did ...w extinct. , But theres good news too. The study,...
Other Biology News:International workshop to address capacity building for rainforest leaders 2International workshop to address capacity building for rainforest leaders 3Harvard researchers publish MRI images of genes in action in the living brain 2Most people believe smallpox not an extinct disease 2
Chicken Anti-PSMD1 Polyclonal Antibody, Unconjugated from ProSci, Inc
Terrific Broth from GE Healthcare, formerly Amersham Biosciences
...ole 1200L sets the new standard for value in today...latest technologies and providing tailored solutio... The Atmospheric Pressure Ionization (API) interf...de superior selectivity and sensitivity for pharma...
Mouse Anti-Human beta IG-H3 Monoclonal Antibody, Unconjugated, Clone 348506 from R&D Systems
Biology Products: